Kings County Hospital Center

Paul Tornetta III, MD, PhD, FAAOS, Named 92nd President of the American Academy of Orthopaedic Surgeons

Retrieved on: 
수요일, 2월 14, 2024
Knowledge, Boston University, SAN, ROCK, Medicine, Doctor of Philosophy, Boston Medical Center, ABOS, Journal of Orthopaedic Trauma, MD, Teaching hospital, Orthopedic surgery, Hospital, Surgeon, Education, SUNY Downstate Medical Center, DSM-IV codes, Annual general meeting, State university system, AOA, Council, Patient, Teaching, OTA, Trauma, Kings County Hospital Center, Curriculum, AAOS, American Academy

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced Boston orthopaedic trauma surgeon Paul Tornetta III, MD, PhD, FAAOS, as its new president for 2024-2025.

Key Points: 
  • SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced Boston orthopaedic trauma surgeon Paul Tornetta III, MD, PhD, FAAOS, as its new president for 2024-2025.
  • In his acceptance speech, Dr. Tornetta said, "I am honored and humbled to serve as AAOS president.
  • As orthopaedic surgeons, we share a strong bond based in helping others.
  • He is past president of the Orthopaedic Trauma Association (OTA) and served on the executive committee of the American Orthopaedic Association (AOA) for more than a decade.

NYC Health + Hospitals/Kings County Becomes First in New York to Introduce MOLLI Surgical's Advanced Technology, Elevating the Breast Cancer Surgery Experience

Retrieved on: 
목요일, 10월 19, 2023
Surgeon, Radiology, Cosmetic, Hope, Kings County Hospital Center, Health, New York City Department of Health and Mental Hygiene, Partnership, Breast cancer, Woman, Anxiety, Patient, Birth control, Dentistry, Medical imaging, Hospital

BROOKLYN, N.Y. and DEERFIELD, Ill., Oct. 19, 2023 /PRNewswire/ -- NYC Health + Hospitals/Kings County joins forces with MOLLI Surgical in a meaningful partnership, introducing breast cancer patients to the transformative MOLLI 2® System. As MOLLI Surgical forges ahead in precision surgery, this award-winning technology — now available to patients in New York — is poised to redefine the landscape of breast cancer surgery, ensuring simpler procedures and an enhanced patient experience.

Key Points: 
  • As MOLLI Surgical forges ahead in precision surgery, this award-winning technology — now available to patients in New York — is poised to redefine the landscape of breast cancer surgery, ensuring simpler procedures and an enhanced patient experience.
  • Surgeons then use the MOLLI Wand® and MOLLI Tablet® to pinpoint these lesions, bypassing the conventional, more painful, hooked-wire marking technique.
  • With the introduction of MOLLI 2, both NYC Health + Hospitals/Kings County and MOLLI Surgical demonstrate their unified commitment to enabling precision surgery made simpler, enhancing clinical efficiency, and elevating the patient and physician experience.
  • MOLLI 2 exemplifies this dedication and promises patients at NYC Health + Hospitals/Kings County a more seamless and compassionate path to recovery.

Talkiatry Co-Founder Dr. Georgia Gaveras Recognized as a 2023 Crain's Notable Health Care Leader

Retrieved on: 
화요일, 5월 16, 2023
Depression, Osteopathic medicine in the United States, Anxiety, Physician, Mount Sinai Morningside, ADHD, Research, Addiction medicine, Roosevelt Hospital (Edison, New Jersey), Columbia University Vagelos College of Physicians and Surgeons, Patient, Child, Medical Center, Touro College of Osteopathic Medicine, Adolescence, Growth, Entrepreneurship, Columbia University College of Dental Medicine, Kings County Hospital Center, Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Bipolar disorder, Nursing, Central New York Business Journal, Surgeon

The Notable Health Care Leader Award recognizes professionals in the New York and northern New Jersey metropolitan areas who devote their lives to building a healthier future.

Key Points: 
  • The Notable Health Care Leader Award recognizes professionals in the New York and northern New Jersey metropolitan areas who devote their lives to building a healthier future.
  • As the leader of Talkiatry's clinical team, Dr. Gaveras focuses on providing quality care and improving patient outcomes at scale.
  • "I am honored to be named one of Crain's Notable Health Care Leaders," said Dr. Gaveras.
  • To view the complete list of Notable Health Care Leaders, please visit here .

TEXAS CHILDREN'S HOSPITAL'S DR. PETER HOTEZ AND DR. MARIA ELENA BOTTAZZI RECEIVE THE 2023 LYNDON B. JOHNSON MORAL COURAGE AWARD

Retrieved on: 
금요일, 5월 12, 2023
Vaccine, Prejudice, Poverty, Society, Diplomacy, COVID-19, Infection, Baylor University, Holocaust Museum Houston, Dean, Business, DRS, Kings County Hospital Center, Research, Science, Lyndon, Philosophy, Apathy, Texas Children's Hospital, LBJ, Tropical medicine, National school, Baylor College of Medicine, Hospital, Kingdom, Health, SR, Family, Dean (education), Pharmaceutical industry

HOUSTON, May 12, 2023 /PRNewswire/ -- Texas Children's Hospital is pleased to announce that Dr. Peter Hotez, Co-Director of the Texas Children's Hospital Center for Vaccine Development and Dean of the National School of Tropical Medicine at Baylor College of Medicine and Dr. Maria Elena Bottazzi, Co-Director of the Center for Vaccine Development at Texas Children's Hospital and Sr. Associate Dean of the National School of Tropical Medicine at Baylor College of Medicine, received the prestigious 2023 Lyndon B. Johnson Moral Courage Award from the Holocaust Museum Houston, for their efforts researching and developing a patent-free, recombinant protein-based COVID-19 vaccine technology for the world's benefit and use.

Key Points: 
  • The LBJ Moral Courage Award is given annually to individuals who have shown the moral courage to stand up against injustice, hatred, prejudice and apathy and who used their influence to change our world for the better.
  • I've also been leading efforts to combat rising antivaccine disinformation and with it, antisemitism," said Dr. Peter Hotez.
  • I dedicate this to scientists and partners around the world who share our philosophy," said Dr. Maria Elena Bottazzi.
  • Hotez and Bottazzi received a Nobel Peace Prize Nomination for their vaccine development work and received Fast Company's 2022 Most Creative People in Business' Award.

TEXAS-DEVELOPED PATENT-FREE COVID-19 VACCINE TECHNOLOGY RECEIVES EMERGENCY USE AUTHORIZATION IN INDONESIA

Retrieved on: 
금요일, 9월 30, 2022
Certification, Bio Farma, Health, Baylor, HMO, COVID-19, Tropical medicine, Twitter, Jan, KAEF, Hospital, Pediatrics, Texas Children's Hospital, Kings County Hospital Center, View, News, Halal certification in the Philippines, Baylor University, Partnership HealthPlan of California, Vaccine, Baylor College of Medicine, INAF, Research, Pharmacy, National school, CVD, Multimedia, Urgent care center, Education, Pharmaceutical industry, Woman

Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.

Key Points: 
  • Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.
  • Indonesia is seeking Halal Certification for the vaccine since no animal cells or products were used in the production of the vaccine.
  • The pharmaceutical company is currently manufacturing Covid-19 primary series vaccine, while booster vaccine is in the clinical trial stage and soon followed by vaccine for children.
  • Bio Farma became a holding company after a merger of three listed state-owned pharmaceutical companies in Indonesia.

Premera Blue Cross Commits $2.3 Million to Expand Access to Behavioral Health, Housing Solutions in Washington, Alaska

Retrieved on: 
화요일, 5월 10, 2022
Child, Progressive house, Blue Cross Blue Shield Association, Investment, United States Public Health Service, Kings County Hospital Center, Hearth, Woman, CQD, Health equity, Health, GLOBE, Social impact, Rural health, Black, El Centro de la Raza, Friendship Circle (organization), Terrace, School, Tacoma–Pierce County Health Department, Community foundation, Trauma, Poverty, Organization, NWCF, Office of Minority Health, Premera Blue Cross, Pacific Northwest, Law enforcement, Homelessness, Friendship Circle, Mental health, Solution, Baseball, Lists of diseases, Curriculum, Edmonds School District, Pharmaceutical industry, Health insurance, Medicine, Hospital, Gold, Transition

Grant recipients include partners focused on improving access to behavioral health care, addressing health inequities, and supporting programs related to the intersection of homelessness and behavioral health.

Key Points: 
  • Grant recipients include partners focused on improving access to behavioral health care, addressing health inequities, and supporting programs related to the intersection of homelessness and behavioral health.
  • This $2.3 million commitment builds on the companys investments in 2021, totaling $6.9 million to organizations focused on behavioral health, homelessness, rural health, and health equity.
  • Since 2017, Premera has worked with and through our partners to create deep, and meaningful changes, Paul Hollie, head of Premera Social Impact.
  • In 2021, Premera committed $6.9 million to 86 organizations, bringing the programs total community investments to $77 million.

TEXAS SCIENTISTS URGE WHITE HOUSE TO COMMIT TO GLOBAL FUNDING OF NON-PATENTED COVID-19 VACCINE

Retrieved on: 
화요일, 4월 26, 2022
Public health, News, Tropical medicine, Urgent care center, DCGI, COVID-19, Pediatrics, Twitter, Research, Neglected tropical diseases, Center, Baylor, Texas Medical Center, Education, National school, Partnership HealthPlan of California, Congress, Hospital, Baylor University, Baylor College of Medicine, PDP, Vaccination, Jan, Vaccine, Health, Kings County Hospital Center, Fermentation, Philosophy, HMO, SEC, Policy, Foreign Affairs Committee, Coronavirus, Safety, Committee, COVID-19 vaccine, Multimedia, Foreign Affairs, Drugs Controller General of India, View, Pharmaceutical industry, Woman, Texas Children's Hospital

HOUSTON, April 26, 2022 /PRNewswire/ -- Texas Children's Hospital announces nearly 30 million doses of CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine technology created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability, have been administered in children across India with second doses currently underway. Originally granted Emergency Use Authorization for distribution in India where more than 500,000 doses are distributed each day, the vaccine has been approved in Botswana, where more than 100 million doses have been procured, which could lead towards its administration in the African continent.

Key Points: 
  • This requires Congressional funding to support worldwide distribution of CORBEVAX, the only safe, effective, low-cost, easily scalable vaccine currently available in the world.
  • Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.
  • "Texas Children's is prepared, ready, and willing to walk together with national and global leaders to vaccinate millions throughout our global community."
  • Texas Children's Hospital Center for Vaccine Development is one of the leading vaccine development centers in the world.

Paul Tornetta III, MD, FAAOS, named second vice president of the American Academy of Orthopaedic Surgeons

Retrieved on: 
목요일, 3월 24, 2022
Knowledge, Curriculum, ROCK, Capitol Region Education Council, Hispanic Scientist of the Year Award, The Foundation for Young Australians, Boston University, Multimedia, Board, Patient, State university system, OTA, Orthopedic surgery, Boston University School of Medicine, American Academy of Orthopaedic Surgeons, Hospital, AOA, Teaching hospital, Council, AAOS, Orthopaedic Research Society, Kings County Hospital Center, MD, Journal of Orthopaedic Trauma, Director, Parable of the Good Samaritan, Surgeon, Boston Medical Center, American Board of Orthopaedic Surgery, American Academy, Academy, Australian Drug Evaluation Committee, Trauma, Degenerative disease, Department, Education, University Hospital of Brooklyn at Long Island College Hospital, Pharmaceutical industry

CHICAGO, March 24, 2022 /PRNewswire/ -- Boston orthopaedic trauma surgeon Paul Tornetta III, MD, FAAOS, was named second vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.

Key Points: 
  • CHICAGO, March 24, 2022 /PRNewswire/ -- Boston orthopaedic trauma surgeon Paul Tornetta III, MD, FAAOS, was named second vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.
  • He is past president of the Orthopaedic Trauma Association (OTA) and served on the executive committee of the American Orthopaedic Association (AOA) for more than a decade.
  • Dr. Tornetta is a highly respected professor known for his teaching prowess and efforts to advance orthopaedic education and training.
  • With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the world's largest medical association of musculoskeletal specialists.

Lyra Therapeutics Appoints Harlan W. Waksal, MD, as Executive Chairman

Retrieved on: 
목요일, 2월 17, 2022
American Committee for East–West Accord, Patient, Ear, Business, Food, Cancer, Tissue, Bureau of Oceans and International Environmental and Scientific Affairs, Legislation, Company, Weizmann Institute of Science, Inflammation, CRS, Oberlin College, Tufts University School of Medicine, Sinusitis, Private Securities Litigation Reform Act, Eli Lilly and Company, Internal medicine, Kings County Hospital Center, Therapy, Sanofi, MD, LinkedIn, Tufts Medical Center, Twitter, FDA, Board, Risk, ImClone Systems, Employment, BA, Failure, Lists of disasters, Acquisition, Food and Drug Administration, Nose, Pathology, Growth, ROCK2, COVID-19, Pharmacotherapy, Paranasal sinuses, Industry, Cetuximab, Management, Pharmaceutical industry, Lyra, Director

WATERTOWN, Mass., Feb. 17, 2022 /PRNewswire/ --Lyra Therapeutics today announced the appointment of Harlan W. Waksal MD, as Executive Chairman.

Key Points: 
  • WATERTOWN, Mass., Feb. 17, 2022 /PRNewswire/ --Lyra Therapeutics today announced the appointment of Harlan W. Waksal MD, as Executive Chairman.
  • "Harlan brings tremendous experience leading late-stage and commercial biotech and pharmaceutical companies.
  • Lyra has granted an equity-based award pursuant to its 2022 Inducement Award Plan to Dr. Waksal.
  • Lyra Therapeutics, Inc.is a clinical-stage therapeutics company leveraging its proprietary XTreo platform to enable precise, sustained, local delivery of medications to diseased tissues not accessible with conventional therapeutic approaches.